Single immunizations of self-amplifying or non-replicating mRNA-LNP vaccines control HPV-associated tumors in mice

J Ramos da Silva, K Bitencourt Rodrigues… - Science Translational …, 2023 - science.org
As mRNA vaccines have proved to be very successful in battling the coronavirus disease
2019 (COVID-19) pandemic, this new modality has attracted widespread interest for the …

[HTML][HTML] Research progress of nanovaccine in anti-tumor immunotherapy

M Yao, X Liu, Z Qian, D Fan, X Sun, L Zhong… - Frontiers in …, 2023 - frontiersin.org
Tumor vaccines aim to activate dormant or unresponsive tumor-specific T lymphocytes by
using tumor-specific or tumor-associated antigens, thus enhancing the body's natural …

Components, formulations, deliveries, and combinations of tumor vaccines

T Liu, W Yao, W Sun, Y Yuan, C Liu, X Liu, X Wang… - ACS …, 2024 - ACS Publications
Tumor vaccines, an important part of immunotherapy, prevent cancer or kill existing tumor
cells by activating or restoring the body's own immune system. Currently, various …

[HTML][HTML] Interleukin-6 and indoleamine-2, 3-dioxygenase as potential adjuvant targets for Papillomavirus-related tumors immunotherapy

RL Pagni, PC Souza, R Pegoraro… - Frontiers in …, 2022 - frontiersin.org
High-risk Human papillomavirus (HPV) infections represent an important public health issue.
Nearly all cervical malignancies are associated with HPV, and a range of other female and …

[HTML][HTML] Current progress in the development of prophylactic and therapeutic vaccines

T Li, C Qian, Y Gu, J Zhang, S Li, N Xia - Science China Life Sciences, 2023 - Springer
Vaccines are essential public health tools and play an important role in reducing the burden
of infectious diseases in the population. Emerging infectious diseases and outbreaks pose …

Design and evaluation of a multi-epitope DNA vaccine against HPV16

L Zhu, X Cui, Z Yan, Y Tao, L Shi, X Zhang… - Human Vaccines & …, 2024 - Taylor & Francis
Cervical cancer, among the deadliest cancers affecting women globally, primarily arises
from persistent infection with high-risk human papillomavirus (HPV). To effectively combat …

Immunotherapeutic approaches for HPV-caused cervical cancer

SA Fatemi, N Seifi, S Rasekh, S Amiri… - Advances in Protein …, 2022 - Elsevier
Cervical cancer, the fourth most frequent women cancer worldwide, is mostly (about 99%)
associated with human papillomavirus (HPV). Despite availability of three effective …

[HTML][HTML] 宫颈癌免疫治疗的耐药机制及应对措施

杨钧媛, 蔡红兵 - 肿瘤防治研究, 2022 - html.rhhz.net
宫颈癌严重威胁全球女性的生命健康, 晚期宫颈癌治疗手段有限, 5 年生存率不到20%,
是妇科肿瘤的巨大挑战. 免疫治疗是晚期宫颈癌患者的重要治疗手段之一 …

[PDF][PDF] Human Papillomavirus and Considerations for Prevention Post-COVID-19

S Nanayakkara - Prevention, 2023 - nccid.ca
Although it is a preventable and potentially curable disease, cervical cancer is still a
common cause of cancer mortality worldwide. Human papillomavirus (HPV) infection is the …

[HTML][HTML] Therapeutic vaccines for human papillomavirus-related cancer: progress and challenges

RL Pagni, GF Pelegrin… - Translational Cancer …, 2022 - tcr.amegroups.org
Therapeutic vaccines for human papillomavirus-related cancer: progress and challenges -
Pagni - Translational Cancer Research Have a website account?Log In orRegister for …